ConductScience.org, home

Library / Trials

Virtual Reality VAlidation Tool for Cognitive Rehabilitation, Oriented Project for People With Psychosocial Disabilieties

NCT05070065, Not applicable, Completed, University of Cagliari

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleVirtual Reality VAlidation Tool for Cognitive Rehabilitation, Oriented Project for People With Psychosocial DisabilietiesClinicalTrials.gov
NCT numberNCT05070065ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment50 participants, actualClinicalTrials.gov
Lead sponsorUniversity of CagliariClinicalTrials.gov
ConditionsMood DisordersClinicalTrials.gov
InterventionsCognitive remedy intervention with virtual reality (CEREBRUM)ClinicalTrials.gov
First posted2021-10-06ClinicalTrials.gov
Last updated2023-03-20ClinicalTrials.gov

Registered outcomes 10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryMemoryAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Rey's Figure Test Word's Figure Test Digit Span Forward and Backward Test Test of the TaleClinicalTrials.gov
PrimaryMonitoring Side effects of Virtual RealityDuring the first VR session - At 1 month (after 8 sessions) - T1 (at 3 months from baseline)Questionnaire (Qualitative)ClinicalTrials.gov
PrimaryAttentionAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Matrix Test Digit Symbol Substitution TestClinicalTrials.gov
PrimaryExecutive functionsAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Trial Making Test Verbal Phonological and Semantic Fluency Test Cognitive Estimation Test - CET Stroop Test Frontal Assessment Battery - FABClinicalTrials.gov
SecondaryQuality of LifeAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Short Form Healthy Survey Questionnaire - SF-12ClinicalTrials.gov
SecondaryAlexithymiaAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Toronto Alexithymia Scale - TAS-20ClinicalTrials.gov
SecondaryAnxietyAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Self Anxiety Rating Scale - SASClinicalTrials.gov
SecondaryDepressionAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)The Patient Health Questionnaire - PHQ-9ClinicalTrials.gov
SecondaryBiological RythmsAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Biological Rythms Interview of Assesment in Neuropsychiatry - BRIANClinicalTrials.gov
SecondaryGeneral and social functioningAll measure at: T0 (base line) -T1 (at 3 months from baseline) -T2 (at 6 months from baseline) -T3 (at 12 months from baseline)Health of the Nation Outcome Scales - HoNOSClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
36983145DERIVEDPubMed
37274852DERIVEDPubMed
39458156DERIVEDPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 4

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Category FluencyPrimary outcomeConductCognition
Digit Span TestPrimary outcomeConductCognition
Stroop Color-Word TestPrimary outcomeConductCognition
Symbol CodingPrimary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)